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Early diabetes mellitus stimulates proximal tubule renin mRNA Early diabetic nephropathy is characterized by hyper-
expression in the rat. trophy of glomeruli and tubular epithelial cells, thick-
Background. Enhanced intrarenal angiotensin II (Ang II) ening of basement membranes, and enhanced renal
activity may contribute to diabetic nephropathy. The proximal
blood flow and glomerular hyperfiltration [1]. This istubule is a proposed site of significant intrarenal Ang II produc-
accompanied by microalbuminuria and subsequent de-tion. We determined the effect of early diabetes on mRNA
expression of components of the proximal tubule renin-angio- velopment of progressive glomerulosclerosis, with accu-
tensin system. mulation of extracellular matrix proteins in the glomeru-
Methods. Three groups of male Sprague-Dawley rats were lar mesangium. In addition, tubulointerstitial fibrosis
studied after two weeks: (1) control (C), (2) streptozotocin-
occurs and correlates with the severity of reduction ininduced diabetes (STZ), and (3) STZ-induced diabetes, with
glomerular filtration rate (GFR) [2, 3].normoglycemia maintained by insulin implants (STZ-I). Com-
The renin-angiotensin system (RAS) has been impli-petitive reverse transcription-polymerase chain reaction was
used to assay mRNA for renin, angiotensinogen, and angioten- cated in the pathogenesis of diabetic nephropathy, based
sin-converting enzyme in suspensions of proximal tubules; in large part on the ability of angiotensin-converting
plasma and kidney levels of Ang II were measured by radioim- enzyme (ACE) inhibitors or angiotensin II (Ang II) sub-munoassay, and Western analysis of Ang II subtype 1 (AT1) type 1 (AT1) receptor blockers to diminish proteinuriareceptors was performed.
and to retard progressive glomerulosclerosis [4, 5]. InResults. STZ rats tended to have increased plasma and intra-
renal levels of Ang II compared with C and STZ-I rats. In prox- addition to its ability to induce systemic and intraglomer-
imal tubules, mRNA for renin was significantly increased in STZ ular hypertension [6] and to increase glomerular capillary
rats, with reversal to control values in STZ-I rats (C, 2432 6 permeability [7], Ang II is a renal growth factor and
437 vs. STZ, 5688 6 890 fg/0.25 mg RNA, P , 0.05 vs. C, N 5
causes hypertrophy of mesangial cells and tubular epi-9, vs. STZ-I, 1676 6 376 fg/0.25 mg RNA, P 5 NS vs. C). In
thelial cells and promotes production of the proscleroticSTZ rats, the AT1 receptor antagonist losartan caused a further
cytokine transforming growth factor-b (TGF-b) [8, 9].fivefold increase in proximal tubule renin mRNA, associated
with proximal tubular renin immunostaining. STZ had no sig- This suggests that intrarenal Ang II activity may be in-
nificant effect on mRNA expression for angiotensinogen or creased in diabetes. In early diabetes, however, several
angiotensin-converting enzyme in proximal tubules. By West- groups have been unable to demonstrate activation ofern blot analysis, cortical and proximal tubule AT1 receptor
the intrarenal RAS. For example, Kalinyak et al reportedprotein expression was significantly decreased in STZ rats.
no significant differences in levels of renal renin or angio-Conclusions. These data suggest activation of the proximal
tubule renin-angiotensin system in early STZ diabetes, medi- tensinogen mRNA in rats two weeks after induction of
ated at least partly by enhanced expression of renin mRNA. diabetes with streptozotocin (STZ) [10], and Correa-
Increased local production of Ang II could contribute to tubu- Rotter, Hostetter, and Rosenberg found no significant
lointerstitial injury in this model.
changes in renal renin mRNA and protein content four
weeks after the induction of diabetes [11]. By contrast,
in STZ diabetic rats after eight weeks, Anderson, Jung,Key words: angiotensin II, renin-angiotensin system, streptozotocin,
tubulointerstitial hypertrophy, diabetic nephropathy. and Ingelfinger demonstrated increased intrarenal renin
mRNA and protein content, as well as enhanced glomer-Received for publication February 22, 2000
ular and renal vascular ACE immunostaining [12].and in revised form July 7, 2000
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to differences in time points of study, although the het- glucose, plasma renin, serum creatinine (performed by
the Ottawa Hospital Biochemistry Laboratory, Ottawa,erogeneous expression of RAS components by cells in
the kidney might also contribute. In this regard, although Ontario, Canada), and plasma Ang II. Kidneys were
immediately removed for further analysis. All proce-the renal proximal tubule contains all components of the
RAS and intraluminal levels of Ang II in the proximal dures were approved by the Animal Care Committee of
the University of Ottawa.tubule are approximately 1000-fold higher than those
circulating in plasma [13], components of the RAS are
Measurement of Ang IIalso expressed in glomeruli and the vasculature [14, 15].
Accordingly, since the proximal tubule is a major site Plasma and kidney Ang II levels were measured by a
radioimmunoassay using anti-Ang II antibody (Phoenixof intrarenal Ang II production, the goal of the present
studies was to determine the effect of early STZ diabetes Pharmaceuticals, Inc., Belmont, CA, USA), monoiodi-
nated 125I-labeled Ang II (Amersham, Arlington Heights,in rats on the expression of components of the proximal
tubule RAS. Our data indicate that proximal tubule re- IL, USA), and Ang II standard as previously reported
[17]. For these measurements, kidney and plasma sam-nin mRNA is significantly up-regulated in early diabetes,
with no change in expression of angiotensinogen or ACE ples were collected from anesthetized rats. For assess-
ment of plasma Ang II levels, blood was collected intomRNA. In diabetic rats, the AT1 receptor antagonist losar-
tan causes a further significant increase in proximal tubule chilled tubes containing methanol. A blood sample was
also taken for hematocrit determination. Blood samplesrenin mRNA expression, associated with tubular renin
protein immunostaining. STZ diabetic rats have significant were centrifuged at 48C for 10 minutes at 100 3 g, and
the supernatant collected and stored at 2208C. One kid-renal hypertrophy, elevation of intrarenal Ang II levels
compared with insulin-treated rats, and decreased cortical ney was removed quickly, weighed, immersed in cold
methanol (100%) and immediately homogenized with aand proximal tubule AT1 receptor expression.
glass homogenizer.
For the analysis of renal Ang II levels, kidney superna-
METHODS
tants were dried overnight in a vacuum centrifuge. The
Animal model dried residue was reconstituted in 4 mL of 50 mmol/L so-
dium phosphate buffer, pH 7.4, containing 1 mmol/L ethyl-Male Sprague-Dawley rats (200 to 300 g) were used for
this study and after acclimatization for five days were enediaminetetraacetic acid (EDTA), 0.25 mmol/L thimero-
sal, and 0.25% heat-inactivated bovine serum albumindivided into three groups: (1) control (C; vehicle injec-
tion), (2) diabetic (STZ; administration of STZ, 65 mg/kg (BSA). Plasma and kidney samples were extracted by
absorption to and elution with 100% methanol fromin 0.1 mol/L sodium citrate buffer, pH 4.0, intraperitone-
ally; Sigma, St. Louis, MO, USA), and (3) diabetic with a phenyl-bonded solid-phase extraction column (Bond-
Elut, Varian) for measurement of angiotensin peptides.insulin implants (STZ 1 I, STZ 65 mg/kg intraperitone-
ally and subcutaneous implantation of a sustained release The eluates were collected and stored at 2208C. Before
radioimmunossay, the eluates were evaporated to dry-insulin implant; Linplant, Linshin, Scarborough, Ontario,
Canada) to maintain euglycemia. The day after adminis- ness under vacuum and reconstituted in assay diluent
(50 mmol/L sodium phosphate, 1 mmol/L EDTA, 0.25tration of STZ, urine was assessed for glucose and ke-
tones using a Keto-Diastix reagent strip (Bayer Inc., mmol/L thimerosal, pH 7.4, containing 2.5 mg heat inac-
tivated BSA/mL) and assayed directly. The reconsti-Etobicoke, Ontario, Canada), and only those animals
with sustained glucosuria were classified as diabetic and tuted extracts were incubated with Ang II antiserum and
125I-radiolabeled Ang II for 48 hours at 48C. Bound andwere assigned to the STZ or STZ-I groups. Rats in the
STZ group received daily injections of one to two units free Ang II were separated by dextran-coated charcoal,
and the supernatants were counted by a computer-linkedof insulin subcutaneously (Humulin L; Eli Lilly and Co.,
Indianapolis, IN, USA) to maintain hyperglycemia but g-counter for five minutes. Results for kidney Ang II
levels are reported in femtomoles per gram kidneyprevent ketosis. In some experiments, STZ rats were
treated with the AT1 antagonist losartan, administered weight. The sensitivity of the Ang II assay is ,5 fmol/g.
The percentage of specific binding for Ang II averagedby an implanted miniosmotic pump at 25 mg/kg/day
(Alza Corp., Palo Alto, CA, USA) beginning 24 hours 38%, with a nonspecific binding of 2%.
Angiotensin II [1–8] and angiotensin [2–8] exhibit sim-after STZ. We have previously used this daily dose of
losartan, administered subcutaneously, in a rat ischemic ilar potencies for the Ang II antisera. Angiotensin [3–8]
was also detected by the Ang II antisera, but the displace-kidney model [16]. All rats were allowed free access to
distilled water and standard rat chow, and urine was ment of 125I-Ang II was not parallel to that elicited by
Ang II. Angiotensin [1–10], angiotensin [2–10], and shortmonitored daily for ketones and glucose. After two weeks,
rats were sacrificed by rapid CO2 narcosis and decapita- COOH-terminal fragments of Ang II were only detected
at concentrations more than 100-fold higher than thosetion, and blood was collected for measurement of plasma
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for Ang II. The Ang II antibody did not display cross- tion mutant cRNA, generated by in vitro transcription
from plasmids containing mutant cDNA sequences. Toreactivity with angiotensin [1–7] at amounts of up to
10,000 fmol. The recoveries of angiotensin peptides generate deletion mutant cDNA, an inverse PCR method
was utilized, essentially as described [19]. Briefly, a par-through the extraction and purification procedures were
determined by adding 125I-Ang II to some of the samples tial cDNA sequence for renin, angiotensinogen, or ACE
was PCR amplified from rat kidney RNA and ligatedimmediately before application to the solid-phase extrac-
tion columns. Ang II levels presented are not normalized into the pCR-Script SK(1) cloning vector (Stratagene,
La Jolla, CA, USA). The renin cDNA PCR product wasbased on the extraction efficiency. The recovery of Ang
II from plasma was 90 to 95% and from tissues was 80 generated with a sense primer, 59-CTGCCACCTTGTT
GTGTGAG-39, and an antisense primer, 59-CCAGTATto 85%.
GCACAGGTCATCG-39 corresponding to bases 1033
Isolation of proximal tubule segments to 1296 of the rat renin cDNA and resulting in a PCR
product of 264 bp [19]. The angiotensinogen cDNA PCRSuspensions of rat proximal tubules were isolated by
collagenase digestion of renal cortices, followed by Per- product was generated with the sense primer 59-CCTCG
CTCTCTGGACTTATC-39 and the antisense primercoll gradient centrifugation, essentially as described [18].
Briefly, renal cortices were dissected, gently minced, and 59-CAGACACTGAGGTGCTGTTG-39, corresponding
to bases 737 to 962 of the rat angiotensinogen cDNAsuspended in a solution containing (in mmol/L) 105
NaCl, 24 NaHCO3, 5 KCl, 1.5 CaCl2, 1.0 MgSO4, 2.0 and resulting in a 226 bp PCR product [19]. Finally, the
ACE cDNA PCR product was generated by amplifica-Na2HPO4, 5 glucose, 1.0 alanine, 4.0 Na lactate, 10
HEPES (pH 7.4), 0.2% BSA, 0.03% collagenase (type tion with the sense primer 59-GCCACATCCAGTATTT
CATGCAGT-39 and the antisense primer 59-AACTGGIV; Sigma), and 0.01% soybean trypsin inhibitor (buffer
A; Sigma). The suspension was gassed with 95% O2/ AACTGGATGATGAAGCTGA-39, corresponding to
bases 3013 to 3454 of the rat ACE cDNA and resulting5% CO2 for 30 minutes at 378C. After digestion, the
cortical suspension was strained through a 250 mm brass in a 441 bp PCR product [20].
Inverse PCR was performed on the plasmids con-sieve and then centrifuged for one minute at 100 3 g.
The pellet was resuspended in buffer A without collagen- taining the renin, angiotensinogen, and ACE partial
cDNA sequences, using sense and antisense primers ori-ase or trypsin inhibitor and was recentrifuged three times
at 100 3 g. The pellet was then applied to a 40% Percoll ented in a “tail-to-tail” direction, thereby amplifying the
cloning vector and a fragment of the cDNA, with a gapsolution of identical ionic composition as buffer A, which
had been previously chilled to 48C. The Percoll solution between the 59 ends of the PCR product [19]. The oligo-
nucleotide primers for inverse PCR of the renin cDNAwas centrifuged at 26,000 3 g for 30 minutes at 48C, and
the digested tissue was separated into four distinct bands, were sense 59-CGACTGAGCGTTGTGAACTGTAG
CCA-39, corresponding to bases 1166 to 1183 of the ratas described [18]. The F4 layer, enriched in proximal
tubular segments, was removed and utilized immediately renin cDNA, and antisense 59-CGACTGAGATATAG
GATGTGCCAGTG-39, corresponding to bases 1093 tofor RNA isolation. The procedure yielded a highly puri-
fied preparation of proximal tubules (97% by micros- 1076 and resulting in a 208 bp deletion mutant product
(deletion of 56 bp). For angiotensinogen, the sensecopy), and viability of segments was .95%, as deter-
mined by exclusion of trypan blue (10 mg/dL). primer, 59-AGCGTCGTTCCAAGGGAAGATGAGA
GGC-39, corresponded to bases 847 to 864 of the rat
Competitive reverse transcription-polymerase angiotensinogen cDNA, and the antisense primer was
chain reaction 59-CGACTGAGTGTCACAGCCTGCACAAACC-39,
corresponding to bases 811 to 791, resulting in a 169 bpTotal RNA was isolated from proximal tubule seg-
ments using a commercial kit (RNeasy; Qiagen, Chats- deletion mutant PCR product (deletion of 57 bp). For
ACE, the sense primer was 59-GTCTCTGCCCTCCAGworth, CA, USA). RNA quality was assessed by running
samples on ethidium bromide-stained 1% agarose-form- TGCCTAG-39, corresponding to bases 3337 to 3358 of
the rat ACE cDNA, and the antisense primer wasaldehyde gels and by measurement of optical density at
260 and 280 nm. RNA yield was between 10 and 25 mg 59-GAAAGTTGATGTCATGCTC-39, corresponding to
bases 3195 to 3177, resulting in a 301 bp deletion mutantper proximal tubule preparation, and all samples were
of high quality, as assessed by these standards. cDNA product (deletion of 141 bp). All inverse PCR
reactions were performed for 35 cycles in a Perkin-ElmerTo quantitate absolute mRNA levels for renin, angio-
tensinogen, and ACE, a competitive reverse transcrip- Gene Amp 2400 PCR thermocycler, with hot-start at
968C for 8 minutes, followed by denaturation at 968Ction-polymerase chain reaction (RT-PCR) assay was per-
formed, using deletion mutant cRNA for each of these for 60 seconds, annealing at 638C for 60 seconds, and
elongation at 728C for 90 seconds. Self-ligation of thecomponents. Each sample of RNA (250 ng) was simulta-
neously reverse transcribed with serial dilutions of dele- PCR product was performed by adding adenosine
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59-triphosphate (ATP; 1 mmol/L) and 10 U of T4 DNA was linear up to 40 cycles of PCR. Accordingly, PCR
was routinely performed for 35 cycles, with a hot-startligase (Stratagene), followed by an overnight incubation
at 178C. Competent TOP 10F9 Escherichia coli bacterial at 968C for 3 minutes, followed by cycles at 948C for 30
seconds, 638C for 30 seconds, and 728C for 45 seconds,cells (Invitrogen, Carlsbad, CA, USA) were transformed
with 4 mL of the ligation reaction, by incubation on ice followed by extension at 728C for 10 minutes.
Following RT-PCR, the PCR products were separatedfor 30 minutes, heat-shock at 428C for 45 seconds, and
incubation in 0.45 mL of broth for 60 minutes at 378C, on 3% agarose gels containing Vistra Green nucleic acid
gel stain (Amersham). To determine the amounts of initialwith shaking at 225 r.p.m. The cells were then plated on
Luria-Bertini-agar and grown up for large-scale plasmid mRNA for renin, angiotensinogen, or ACE, signals from
the PCR products and their corresponding deletion mu-preparations, using a Qiagen maxi-plasmid kit. To con-
firm correct sequences and orientation, all deletion mu- tants were quantitated by PhosphorImager analysis (Storm
860; Molecular Dynamics, Sunnyvale, CA, USA). Thetants were sequenced in the University of Ottawa DNA
sequencing facility. logarithms of the ratio of target to deletion mutant (com-
petitor) species were plotted as a function of the initialRenin, angiotensinogen, and ACE RNAs were synthe-
sized from deletion mutant plasmids, using T3 or T7 amount of deletion mutant RNA in the reverse transcrip-
tion reaction. The initial amount of target mRNA wasRNA polymerase (Stratagene). The plasmids were lin-
earized by restriction enzyme digestion, and the tran- quantitated by extrapolating from the point on each
curve where the amount of amplified target was equalscription was carried out for two hours at 378C with 1 mg
of linearized plasmid DNA; 400 mmol/L each of ATP, to the amount of amplified deletion mutant. Experiments
were eliminated from analysis if the correlation of fitcytidine 59-triphosphate (CTP), guanosine 59-triphos-
phate (GTP), and uridine 59-triphosphate (UTP); and (r 2) for the generated curve was less than 0.9.
10 U/mL of T3 or T7 RNA polymerase in 40 mmol/L
Immunohistochemistry for reninTris-HCl (pH 8.0), 50 mmol/L NaCl, 30 mmol/L dithi-
othreitol, 8 mmol/L MgCl2, and 40 mmol/L EDTA. The Rat kidneys were immersed in Zamboni’s fixative (2%
paraformaldehyde, 15% picric acid in 0.1 mol/L phos-template was then degraded with amplification grade
DNase I (Life Technologies, Burlington, Ontario, Can- phate buffer, pH 7.3) at 48C overnight. The kidneys were
then rinsed with 0.1 mol/L phosphate-buffered salineada), and the RNA products were purified by phenol/
chloroform extraction and ethanol precipitation. RNA containing 10% sucrose and incubated overnight at 48C.
Tissue was mounted in paraffin blocks, and 5 mm sectionswas quantitated by absorbance at 260 nm.
For competitive RT-PCR reactions, prior to reverse were cut with a microtome and placed on microscope
slides. Deparaffinization was performed by heating thetranscription, all RNA samples were digested with ampli-
fication grade DNase I (Life Technologies) for 15 min- slides at 608C for 5 minutes and then incubating in xylene
for 15 minutes at room temperature. The sections wereutes at room temperature to remove any residual geno-
mic DNA. The DNase was inactivated by addition of rehydrated by sequential incubation in 100, 95, and 70%
ethanol for five minutes each at room temperature. The2.5 mmol/L EDTA (final concentration) to the reaction
mixture. Samples of RNA (total RNA and dilutions of sections were then washed in distilled water for 2 min-
utes, and endogenous peroxidase activity was blockeddeletion mutant RNA for either renin, angiotensinogen,
or ACE) were then reverse transcribed using random with 0.3% hydrogen peroxide treatment for 30 minutes.
The sections were then permeabilized with 20 mg/mLhexamers (2.5 mmol/L) and murine leukemia reverse
transcriptase (2.5 U/mL; Gene Amp RNA PCR kit; Per- proteinase K in Tris-buffered saline (TBS; 0.1 mol/L, pH
7.7) with Tween-20 for 15 minutes at room temperature.kin-Elmer, Branchburg, NJ, USA). To control for possi-
ble genomic or plasmid DNA contamination, all experi- The slides were then incubated overnight at 48C with
mouse anti-rat renin monoclonal antibody (Swant, Bel-ments included a reaction in which reverse transcriptase
was selectively omitted from the transcription buffer. linzona, Switzerland), diluted 1:20 in 0.6% Tris-carra-
geenan and 0.3% triton-X-100 (TCT) in TBS. The slidesFollowing reverse transcription, the cDNA mixture
was amplified by PCR, in a 100 mL solution containing were then washed twice with TBS and incubated with
anti-mouse biotinylated whole antibody (1:20 in TCT;2.5 U AmpliTaq DNA polymerase, 2 mmol/L MgCl2,
1 3 PCR Buffer II (Perkin-Elmer), and 1 mmol/L each Amersham) for one hour at room temperature. After
washing with TBS, the sections were further incubatedof the sense and antisense oligonucleotide PCR primers
for the cDNA of interest. The sense and antisense prim- with 1:20 dilution of streptavidin-horseradish peroxidase
(Amersham) in TCT for one hour at room temperatureers for renin, angiotensinogen, and ACE were identical
to those used to generate the nonmutant PCR products and then washed twice in TBS and incubated with 3,39-
diaminobenzidine chromogen solution (DAB; Biogenex;described previously in this article, of 264, 226, and 441
bp sizes, respectively. Preliminary experiments revealed ESBE Scientific, St. Laurent, Quebec, Canada) for five
minutes. All slides were counterstained in methylenethat the yield of PCR products for all three components
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green for five seconds, washed in water, and dehydrated Bonferroni correction for all pair-wise comparisons. Sig-
in 95 and 100% ethanol and xylene. The slides were nificance was assigned at P , 0.05.
covered with Permount (Fisher Scientific, Nepean, On-
tario, Canada) and a cover slip and were viewed with a
RESULTSZeiss Axioplan microscope.
Whole animal data
Western blot analysis of the AT1 receptor As shown in Table 1, at the time of sacrifice, STZ-
Proteins from kidney cortices and proximal tubules rats had significant hyperglycemia (plasma glucose: STZ,
of C, STZ, and STZ-I rats were isolated, essentially as 25.1 6 2.2 mmol/L vs. C, 8.14 6 0.16 mmol/L, P ,
described [21]. Briefly, tissue was homogenized in a 0.001). In STZ-I rats, plasma glucose levels did not differ
buffer containing 10% glycerol, 20 mmol/L Tris-HCl, significantly from those in control rats. STZ rats experi-
100 mmol/L NaCl, 2 mmol/L phenylmethylsulfonyl fluo- enced significant weight loss over the two-week period,
ride, 2 mmol/L EDTA, 2 mmol/L EGTA, 10 mmol/L consistent with other studies using this model [24–26].
sodium orthovanadate, 10 mg/L leupeptin, and 10 mg/L
Kidney weights were significantly increased in STZ-rats
aprotinin. The homogenate was centrifuged at 30,000 3 g
(STZ, 1.54 6 0.03 g vs. C, 1.27 6 0.04 g, P , 0.05), andfor 30 minutes at 48C. The resulting pellet was resus-
this was completely reversed in the STZ-I rats (1.24 6pended in the homogenization buffer, which also con-
0.03 g). There were no significant differences in serum cre-tained 1% Nonidet P40, and was then stirred for two
atinine levels among the three groups. Similarly, plasmahours at 48C. The lysate was then centrifuged at
renin activity was not altered in STZ or STZ-I rats.30,000 3 g for 30 minutes at 48C, and the supernatant
was removed and utilized for Western analysis. Plasma and kidney Ang II levels
Protein concentrations in the supernatant were deter-
In STZ rats, plasma Ang II levels were increased com-mined by the Bradford method (Bio-Rad, Montreal, Que-
pared with control and STZ-I rats, although this did notbec, Canada) using BSA as the standard. Tissue lysates
reach statistical significance (C 339 6 64 pmol/L vs. STZ(20 to 40 mg) and prestained molecular weight markers
625 6 202 pmol/L vs. STZ-I 90 6 55 pmol/L; Fig. 1).(Bio-Rad) were loaded onto sodium dodecyl sulfate-poly-
Indeed, plasma Ang II levels were significantly decreasedacrylamide electrophoresis gels (SDS-PAGE; 5% acryl-
in STZ-I rats, compared with C, by one-way analysis ofamide stacking gel and 10% running gel). The resolved
variance (ANOVA; P , 0.02, N 5 3 to 7). Similarly,proteins were transferred onto nitrocellulose membranes
(Bio-Rad). The membranes were blocked overnight at although whole kidney Ang II levels in the STZ rat group
48C with 3% skimmed milk in TBS, pH 7.6. Membranes were higher than kidney levels in C rats, this did not
were incubated with a rabbit anti-rat polyclonal AT1 re- achieve statistical significance (C 244 6 64 fmol/g vs.
ceptor antibody (Santa Cruz Biotechnology, Santa Cruz, STZ 545 6 124 fmol/g, P 5 0.09, N 5 6 to 7). Kidney
CA, USA) diluted 1:1000 in TBS containing 0.01% Ang II levels in STZ rats were significantly higher, how-
Tween 20 (TBS-T), with 2% skimmed milk for two hours ever, than those in STZ-I animals (STZ-I 266 6 53
at room temperature. After washing with TBS-T, mem- fmol/g, P , 0.04 vs. STZ, N 5 4 to 7).
branes were incubated with anti-rabbit secondary anti-
body conjugated to horseradish peroxidase (Amersham, Proximal tubule mRNA expression for renin,
Mississauga, ON, Canada), diluted 1:2000. Proteins were angiotensinogen, and ACE
detected by enhanced chemiluminescence (ECL; Amer- Expression of mRNA for renin, angiotensinogen, and
sham) on Hyperfilm (Amersham). Two major protein ACE was readily detectable in rat proximal tubule sus-
bands (approximately 41 kD and approximately 53 kD) pensions, using RT-PCR. By competitive RT-PCR with
were detected for the AT1 receptor on Western blot, deletion mutants, STZ caused a significant increase in
likely representing the nonglycosylated and glycosylated
mRNA expression for renin in the proximal tubule (Cforms of the receptor, respectively [22, 23]. To ensure
2432 6 437 fg/0.25 mg RNA vs. STZ 5688 6 890 fg/equal loading of proteins, membranes were stripped and
0.25 mg RNA, P , 0.05, N 5 9; Fig. 2), an effect thatreprobed with a monoclonal anti-b-actin antibody (mouse
was reversed in STZ-I rats (1676 6 376 fg/0.25 mg RNA).ascites fluid; Sigma), which recognizes the b-actin protein
In STZ rats, treatment with the AT1 receptor antagonistat approximately 45 kD. Signals on Western blots were
losartan (25 mg/kg/day by osmotic minipump) caused aquantitated by densitometry and corrected for the b-actin
further fivefold increase in proximal tubule renin mRNAsignal, using the Kodak Digital Image station 440CF and
expression (STZ 9321 6 1754 fg/0.25 mg RNA vs. STZ 1the ID Image Analysis software program.
losartan 52,465 6 15,003 fg/0.25 mg RNA, P , 0.025,
Statistics N 5 5; Fig. 3). In contrast, neither STZ or STZ-I had
any significant effect on proximal tubule mRNA expres-Results are expressed as means 6 SEM. Data were
analyzed by one-way analysis of variance followed by sion for angiotensinogen (Fig. 4) or ACE (Fig. 5).
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Table 1. Whole animal data
Body weight Kidney weight
Plasma glucose Serum creatinine Plasma renin activity
Condition g mmol/L lmol/L ng/L/second
C 379.569.4 1.2760.04 8.1460.16 52.161.1 1.8560.26
STZ 325.265.1a 1.5460.03b 25.162.20b 55.462.1 2.1460.32
STZ-I 346.364.8 1.2460.03 7.6161.39 51.861.8 1.7560.30
Results are means 6 SEM for N 5 9 to 16. Abbreviations are: C, control; STZ, streptozotocin; STZ-I, streptozotocin plus insulin implant.
a P , 0.001 vs. C
b P , 0.001 vs. C and STZ-I
Fig. 1. Plasma and kidney angiotensin II (Ang II) levels. Ang II was
Fig. 2. Increased proximal tubule renin mRNA in streptozotocinmeasured in plasma (j; in pmol/L) and in whole kidney ( ; in fmol/g),
(STZ)-diabetes. (A) Representative ethidium bromide-stained agaroseas described in the Methods section. Abbreviations are: C, control;
gel of competitive RT-PCR reaction for renin. Lanes 1–3: control (C)STZ, streptozotocin-diabetic rats; STZ-I, streptozotocin-diabetic rats
samples, with 10, 2, and 0.5 pg of deletion mutant RNA utilized, respec-with insulin implants. Results are means 6 SEM; the values in parenthe-
tively. Lanes 4–6: STZ samples, with 10, 2, and 0.5 pg deletion mutantses represent numbers of experiments. *P , 0.04 vs. STZ-I; **P , 0.02
RNA, respectively. Lanes 7–9: STZ rats with insulin implant (STZ-I)vs. C by one-way ANOVA.
samples, with 10, 2, and 0.5 pg deletion mutant RNA, respectively.
Bands representing the 264 bp renin PCR product and the 208 bp
deletion product are indicated. The first lane at left is a 100 bp DNA
ladder. (B) Effect of STZ diabetes on renin mRNA. Means 6 SEM
Renin immunostaining are shown, and values in parentheses are the numbers of separate
experiments. *P , 0.05 vs. C or vs. STZ-I.To determine whether renin protein could be detected
in proximal tubules by immunohistochemistry, rat kid-
ney sections were stained with a mouse anti-rat mono-
clonal antibody against renin. In control and STZ rats, no staining was observed in sections in which the primary
antibody was omitted (Fig. 6D).prominent renin staining was observed in juxtaglomeru-
lar afferent arterioles and also within glomerular endo-
Expression of renal cortical and proximal tubulethelial cells (Fig. 6A). In STZ rats treated with losartan,
AT1 receptorshowever, in which a marked increase in proximal tubule
renin mRNA was detected, staining for renin was ob- Previous studies have demonstrated decreased specific
binding for Ang II in glomeruli and proximal tubules inserved in cortical proximal tubules, predominantly along
the apical membranes (Fig. 6B, C). As a negative control, early STZ diabetes [27–29]. Since we detected increased
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Fig. 3. Effect of losartan on proximal tubule renin mRNA expression.
(A) Representative agarose gel of RT-PCR samples. Lanes 1–3: C, with
50, 10, and 1 pg deletion mutant RNA, respectively. Lanes 4–6: STZ,
with 50, 10, and 1 pg deletion mutant RNA, respectively. Lanes 7–9:
Fig. 4. Effect of STZ-diabetes on proximal tubule angiotensinogenSTZ 1 losartan, with 50, 10, and 1 pg deletion mutant RNA, respec-
mRNA. (A) Representative ethidium bromide-stained agarose gel oftively. The first lane at left is a DNA 100 bp ladder. (B) STZ rats were
competitive RT-PCR reaction for angiotensinogen. Lanes 1–3: C sam-treated without (STZ) or with losartan (STZ 1 LOS), as described in
ples, with 10, 2, and 0.2 pg deletion mutant RNA, respectively. Lanesthe Methods section, and proximal tubule renin mRNA was quantitated
4–6: STZ samples, with 10, 2, and 0.2 pg deletion mutant RNA, respec-by competitive RT-PCR. Control rats (C) received vehicle injection
tively. Lanes 7–9: STZ-I samples, with 10, 2, and 0.2 pg deletion RNA,only. Values in parentheses represent numbers of individual experi-
respectively. Bands depicting the 226 bp angiotensinogen PCR productments. *P , 0.025 vs. STZ.
and the 169 bp deletion product are indicated. The first lane at left is
a 100 bp DNA ladder. (B) Effect of STZ diabetes on angiotensinogen
mRNA. Means 6 SEM are shown, and values in parentheses are num-
bers of separate experiments. P 5 NS for all comparisons.
renin mRNA in proximal tubules in STZ rats and since
kidney Ang II levels tended to increase in this group,
we determined the effect of early STZ diabetes on whole
for angiotensinogen or ACE. The AT1 antagonist losar-cortical and proximal tubule protein expression of AT1
tan, an agent used to prevent the progression of diabeticreceptors. On Western blots, two major bands were ob-
served for the AT1 receptor, one at approximately 41 kD nephropathy in humans, caused a significant further in-
and the other at approximately 53 kD, the latter likely crease in proximal tubule renin mRNA, associated with
representing the glycosylated form of the receptor, as tubular immunostaining for renin on kidney sections.
described (Fig. 7) [22, 23]. Western blot analysis revealed We observed increased intrarenal levels of Ang II in
a significant decrease in cortical AT1 receptor expression rats with diabetes, compared with insulin implant-treated
in STZ rats (both 41 and 53 kD bands), and this was STZ rats. It is also noteworthy that insulin implant ther-
reversed with insulin implant therapy (C 10.34 6 0.19 apy to induce normoglycemia prevented the increase
vs. STZ 6.15 6 0.61 vs. STZ-I 9.07 6 0.25 arbitrary in proximal tubule renin mRNA. Finally, there was a
units; P , 0.001, C or STZ-I vs. STZ, N 5 6). Similarly, significant decrease in expression of cortical and proxi-
proximal tubule AT1 receptor protein expression was mal tubule AT1 receptors in diabetic rats. Taken to-significantly decreased in STZ rats (C 1.92 6 0.20 vs. gether, these data suggest that the proximal tubule RAS
STZ 1.33 6 0.18 arbitrary units, P , 0.05, N 5 6).
is activated in early diabetes and may lead to increased
local production of Ang II. With AT1 blockade, there
DISCUSSION may be a further increase in proximal tubule Ang II
synthesis, with this Ang II free to bind to available intra-The major finding of this study is that early diabetes
renal AT2 receptors. Activation of AT2 receptors iscauses significant stimulation of mRNA expression for
renin in the proximal tubule, with no effect on mRNA linked to depression of blood pressure [30] and inhibition
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to reveal small but important changes in renin produc-
tion. Indeed, the present studies indicate that with a
fivefold increase in proximal tubule renin mRNA (with
losartan), immunohistochemical staining for tubular re-
nin was readily evident. Furthermore, our localization
data are in agreement with studies in mouse kidney,
where renin has been reported in the apical portions of
proximal tubule cells, at high antiserum concentrations
[34].
Competitive RT-PCR was used to quantitate message
for renin, angiotensinogen, and ACE in proximal tubule
segments. In preliminary experiments, we determined
that our assay method reliably produced linear competi-
tive amplification curves, as described [19], and we could
detect changes in mRNA expression exceeding 20%.
Thus, it is possible that smaller changes in proximal tu-
bule angiotensinogen or ACE mRNA expression in dia-
betes were not detected in these studies. Aside from
the proximal tubule, within the kidney renin mRNA
expression predominantly occurs in cells of the afferent
arteriole [35]. The purity of our proximal tubule prepara-
tion was high (,97%), and it is unlikely that significant,
consistent contamination with afferent arterioles oc-
Fig. 5. Effect of STZ-diabetes on proximal tubule angiotensin con- curred that could have influenced the results.
verting enzyme (ACE) mRNA. (A) Representative ethidium bromide- Stimulation of proximal tubule renin mRNA in diabe-
stained agarose gel of competitive RT-PCR reaction for ACE. Lanes
tes is consistent with the studies of Anderson, Jung, and1–3: C samples, with 5, 1, and 0.2 pg deletion mutant RNA, respectively.
Lanes 4–6: STZ samples, with 5, 1, and 0.2 pg deletion mutant RNA, Ingelfinger [12] and Choi et al [36], who demonstrated
respectively. Lanes 7–9: STZ-I samples, with 5, 1, and 0.2 pg deletion increased renal cortical renin mRNA by Northern analy-
mutant RNA, respectively. Bands depicting the 441 bp ACE RT-PCR
sis in STZ diabetic rats. However, other investigatorsproduct and the 301 bp deletion product are indicated. The first lane
at left is a 100 bp DNA ladder. (B) Effect of STZ-diabetes on ACE have not found increases in total renal renin mRNA
mRNA. Means 6 SEM are shown, and values in parentheses are num- expression in experimental diabetes [10, 11]. Because
bers of experiments. P 5 NS for all comparisons.
renin mRNA is derived from multiple sources within the
kidney, it is possible that these data reflect the limited
sensitivity of detection of changes in mRNA expression
for renin in whole kidney. Our study is the first to exam-of renal interstitial fibrosis [31], both desirable effects in
the management of diabetic nephropathy. ine RAS expression in proximal tubules in diabetes, a site
of high production of Ang II, and a target for diabetes-We utilized the well-described STZ rat model of diabe-
tes, and observed the characteristic elevations of plasma induced TGF-b production and hypertrophy [9]. In-
creased proximal tubule renin expression could lead toglucose, loss of body weight, and renal hypertrophy after
two weeks [24–26]. Plasma renin activity did not signifi- stimulation of angiotensinogen conversion to the deca-
peptide Ang I, which may be converted to Ang II eithercantly change in the diabetic animals, with or without
insulin implants, consistent with other reports [10, 11]. intracellularly or following secretion into the tubular lu-
men, via membrane-bound ACE. Increased proximalSTZ diabetes has been associated with tubulotoxicity in
the kidney, formation of microfilament aggregates in tubule Ang II production in early diabetes might pro-
mote tubular cell hypertrophy and interstitial fibrosis,proximal tubule [32], and impaired tubular protein deg-
radation [33]. The stimulatory effect of STZ diabetes on hallmarks of diabetic nephropathy.
Whole-kidney Ang II levels were elevated in STZ rats,proximal tubule renin mRNA was unlikely to be due to
direct toxicity of STZ, however, since insulin implant although the increase did not reach statistical significance
compared with C animals. This may reflect the relativetreatment reversed this effect. Accordingly, this suggests
that hyperglycemia may directly stimulate renin expres- insensitivity of measurements of whole tissue Ang II
when assessing proximal tubule Ang II production insion in the proximal tubule. Although we were unable
to demonstrate significant proximal tubule immunoreac- the kidney, since other cells (for example, glomeruli,
vasculature) may contribute to intrarenal Ang II synthe-tivity for renin in STZ rats, this does not exclude the
possibility for enhanced local renin production, since the sis [14, 15]. In insulin implant-treated STZ rats, kidney
Ang II levels were significantly decreased compared withimmunodetection method may not be sensitive enough
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Fig. 6. Effect of losartan on proximal tubule renin protein expression in STZ rats. Immunohistochemistry for renin was performed on rat kidney
sections, from STZ (A) or STZ 1 losartan-treated rats (B and C ). In STZ rat kidney, renin immunostaining was observed in afferent arterioles
(arrow) and within glomeruli, predominantly in endothelial cells. In losartan-treated STZ rats, renin immunostaining was seen in afferent arterioles
(arrow) and in glomeruli and was also observed in cortical proximal tubules, mainly in the apical region of cells (arrowheads, B and C).
Photomicrograph (D) is a representative section in which staining was performed in the absence of primary antibody, as a negative control. All
photomicrographs are representative of sections from three to four separate rats. Magnification 3400.
STZ rats, and plasma Ang II levels were significantly Zhang et al noted previously [37, 38]. This may be due
to the more prolonged exposure to high glucose, as wellless than levels in C rats. This suggests that insulin may
down-regulate expression and activity of the intrarenal as the involvement of other regulatory factors in the in
vivo model. Furthermore, proximal tubules were isolatedRAS, independent of any effect of hyperglycemia. In
this regard, Zhang et al have determined that acute expo- in the presence of normal (5 mmol/L) glucose concentra-
tions in the present studies, which may have caused acutesure (24 hours) to high extracellular glucose stimulates
angiotensinogen gene expression in immortalized rat changes in angiotensinogen or ACE mRNA expression.
After eight weeks of STZ diabetes, Anderson, Jung,proximal tubular cells in culture, an effect reversed by
insulin treatment, although effects on renin mRNA were and Ingelfinger reported a decrease in total renal ACE,
with a decrease in immunoreactive tubular ACE and annot addressed in these studies [37, 38].
We observed no significant change in mRNA expres- increase in glomerular ACE [12]. In humans with type II
diabetes and nephropathy, a slight decrease in proximalsion for angiotensinogen in proximal tubule in rats with
early diabetes, and although there was an increase in tubular ACE staining has been reported on renal biop-
sies [39]. In Biobreeding (BB) spontaneously diabeticproximal tubule ACE mRNA, this did not reach statisti-
cal significance. The lack of effect on angiotensinogen rats, Everett et al observed an increase in immunoreac-
tive angiotensinogen in proximal tubule after four andgene expression differs from the cell culture data of
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In summary, this study indicates that there is selective
up-regulation of renin mRNA in the proximal tubule in
early STZ diabetes, and that the process is reversed by
insulin therapy. We postulate that this leads to increased
local synthesis of Ang II and is associated with a reduc-
tion in tubular AT1 receptor expression. This may lead
to enhanced Ang II intracellular signaling, promoting
the characteristic tubulointerstitial hypertrophy of early
diabetes.
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